POPULARITY
Categories
Investor Fuel Real Estate Investing Mastermind - Audio Version
In this episode, Logan Pulliza shares his journey from a corporate job to becoming a successful general contractor and real estate investor. He discusses off-market deal acquisition, distressed property turnarounds, and strategies for scaling in the real estate industry. Professional Real Estate Investors - How we can help you: Investor Fuel Mastermind: Learn more about the Investor Fuel Mastermind, including 100% deal financing, massive discounts from vendors and sponsors you're already using, our world class community of over 150 members, and SO much more here: http://www.investorfuel.com/apply Investor Machine Marketing Partnership: Are you looking for consistent, high quality lead generation? Investor Machine is America's #1 lead generation service professional investors. Investor Machine provides true 'white glove' support to help you build the perfect marketing plan, then we'll execute it for you…talking and working together on an ongoing basis to help you hit YOUR goals! Learn more here: http://www.investormachine.com Coaching with Mike Hambright: Interested in 1 on 1 coaching with Mike Hambright? Mike coaches entrepreneurs looking to level up, build coaching or service based businesses (Mike runs multiple 7 and 8 figure a year businesses), building a coaching program and more. Learn more here: https://investorfuel.com/coachingwithmike Attend a Vacation/Mastermind Retreat with Mike Hambright: Interested in joining a "mini-mastermind" with Mike and his private clients on an upcoming "Retreat", either at locations like Cabo San Lucas, Napa, Park City ski trip, Yellowstone, or even at Mike's East Texas "Big H Ranch"? Learn more here: http://www.investorfuel.com/retreat Property Insurance: Join the largest and most investor friendly property insurance provider in 2 minutes. Free to join, and insure all your flips and rentals within minutes! There is NO easier insurance provider on the planet (turn insurance on or off in 1 minute without talking to anyone!), and there's no 15-30% agent mark up through this platform! Register here: https://myinvestorinsurance.com/ New Real Estate Investors - How we can work together: Investor Fuel Club (Coaching and Deal Partner Community): Looking to kickstart your real estate investing career? Join our one of a kind Coaching Community, Investor Fuel Club, where you'll get trained by some of the best real estate investors in America, and partner with them on deals! You don't need $ for deals…we'll partner with you and hold your hand along the way! Learn More here: http://www.investorfuel.com/club —--------------------
How many times should you call a distressed seller before giving up? In this inspiring episode, Brent Daniels sits down with Kim Young, a true Rhino Tribe success story from Chicago, to talk about the power of persistence, gut instinct, and refusing to be crippled by creative avoidance. Kim shares exactly how he netted an incredible 42,500 dollar assignment fee by calling an angry heir back five times after she hung up on him, and why he completely ignored traditional logic by calling an out-of-state lead seven times in a row at 8:30 at night. You will learn why driving for dollars and agent outreach are the two fastest ways to get a deal with zero marketing budget, and why you should never become someone else's employee under the disguise of a Joint Venture. Be a part of the TTP training program now.---------Show notes:(0:00) Beginning of today's episode(1:52) Why Kim believes he has never failed at anything, only learned life lessons(2:59) Getting his first deal by walking up to a stressed property owner in person(3:50) Making 25,000 dollars from a 75 dollar "We Buy Houses" car magnet(7:17) Conquering creative avoidance and getting back on the phone to generate revenue(9:06) How staying in touch with a Tennessee developer led to a massive 30,000 dollar JV deal (12:43) Why you should reject JV offers that turn you into someone else's employee (14:13) Landing a 42,500 dollar deal after a seller explicitly told him to stop calling (19:12) Why driving for dollars and agent outreach are the best strategies for beginners (21:18) The absolute power of trusting your gut instincts and being relentless on the phone (23:18) How to connect with Kim for JV deals and advice in the Chicago market----------Resources:Connect with Kim directly via email: kimyginvestments@gmail.comTo speak with Brent or one of our other expert coaches call (281) 835-4201 or schedule your free discovery call here to learn about our mentorship programs and become part of the TribeGo to Wholesalingincgroup.com to become part of one of the fastest growing Facebook communities in the Wholesaling space. Get all of your burning Wholesaling questions answered, gain access to JV partnerships, and connect with other "success minded" Rhinos in the community.It's 100% free to join. The opportunities in this community are endless, what are you waiting for?
Two small businesses can form an 8(a) joint venture to pursue federal contracts neither could win alone, splitting accounting, bonding, and delivery responsibilities under the program rules. David Rambhajan, a contractor who grew through joint ventures and mentor-protege agreements before selling his company, walks through how he used partnering to gain past performance, limit his bonding indemnification, and pull retained earnings from two ventures to fuel his own growth. What you'll learn in this episode: How two small businesses combine capabilities in a joint venture to reach contracts neither could win alone Why every joint venture job counts as past performance for your own business How to negotiate bonding and indemnification so a partnership grows your company instead of draining it The mentor-protege agreement as a tool to learn federal contracting from a larger, established partner Why vetting a partner's values before signing matters as much as the contract itself Chapters: 0:00 - Splitting responsibilities when teaming and partnering 0:52 - Two small businesses combining capabilities to grow 1:36 - Joint venturing as a serious, marriage-like relationship 2:20 - Vetting a partner's values before you sign 3:17 - Why relationship work never gets the credit 4:06 - Learning the business while leaning on a partner 5:31 - Using the 8(a) program to hedge risk 6:04 - Negotiating the bonding indemnification instead of signing 8:32 - Pulling profit from two ventures to fuel growth Mindy gives you the federal opportunities, agency signals, recompete intel, and pursuit briefs that tell you not just what contracts exist, but which ones to chase and how to win them. Sign up for free Daily Alerts and get opportunities delivered to your inbox before the day starts.
00:00 Intro01:16 $60B Lost to Transshipment Scams Annually: WH Report 01:55 China Builds Transshipment Network to Evade Tariffs 02:56 White House Announces AI System to Detect Transshipment 03:48 Court Backs Trump's End to ‘De Minimis' Loophole 06:29 Microsoft Shuts 15 Offices, Joint Ventures in China 07:50 Ford to Move Some SUV Production Back to U.S. 08:24 On the Ground During Taiwan's Air Raid Drill 09:11 What Is Taiwan Preparing for in Air Raid Drill? 10:32 Xi Orders China Military: Be Ready for Taiwan by 2027 10:44 Putin Visits Disputed Kuril Islands; Japan Protests 13:14 Taiwan Thwarts AI Cyberattacks 13:58 U.S. Must Rebuild Hard Power to Counter China: Col. Newsham 14:16 Philippines Wakes Up to China's Political Warfare 18:50 “Don't Help Them”: A Reagan Strategy for Today
In this episode, Alan Condon, Editor-in-Chief at Becker's Healthcare, discusses the surge in health system M&A, including the proposed Intermountain Health and AdventHealth joint venture in Colorado and Salem Health's merger with Santiam Memorial Hospital in Oregon. He also explores how financial pressures, regulatory flexibility and the need for greater scale are shaping health system partnerships and transactions.
Korean manufacturer Samsung SDI announced that it acquired General Motors' stake in the SynergyCells joint venture. The collaboration had planned to build a $3.5 billion electric vehicle battery cell factory in New Carlisle, Indiana, with the American automaker holding a 49.99% stake.Samsung SDI attributed the decision to market changes since the joint venture's conception in 2023, including “slower-than-expected growth of EV demand.” The company said it plans to continue building the facility, which would serve as its first independently operated battery production base in North America. The plant is currently under construction, though Samsung SDI did not provide an expected completion date. Once finished, the company now plans to make batteries for energy storage systems. Despite GM's exit from the joint venture, the two companies signed a new agreement to develop a prismatic battery cell for potential future EV applications, with Samsung SDI noting that the Indiana plant could eventually make the cells.General Motors and Samsung SDI formed their original partnership in April 2023 and selected New Carlisle as the plant site two months later. The joint venture intended to make nickel-rich prismatic and cylindrical cells, achieve a capacity of 30 gigawatt-hours, create 1,600 jobs and begin production in 2026. However, in August 2024, the companies delayed the production start to 2027 after construction had begun.GM's decision to sell its stake follows a January 8 SEC filing in which the automaker said it expected to record approximately $6 billion in charges in the fourth quarter of 2025 following its review of EV capacity and investments. The announcement comes as automakers scale back EV plans after the loss of a $7,500 EV federal tax credit last September.#GM, #GeneralMotors, #SamsungSDI, #EV, #ElectricVehicles, #EVBatteries, #BatteryManufacturing, #EnergyStorage, #Manufacturing, #IndianaManufacturing, #Automotive, #BatteryTechnology, #SupplyChain, #IndustrialNews, #ManufacturingNews
Jennifer Hutchens, Partner, Dechert LLP, and Thomas Spellman, Associate General Counsel & Vice President, Fresenius Medical Care, discuss the role that joint ventures are currently playing in the health care industry and what to expect when engaging in a joint venture. They cover why joint ventures are so popular right now and issues related to the corporate practice of medicine, the Stark Law and Anti-Kickback Statute, antitrust, financial provisions and reporting rights, and restrictive covenants. They also share some hot spots they have seen in their own practices. Jennifer and Thomas spoke about this topic at AHLA's 2026 Health Care Transactions conference in Nashville, TN.Watch this episode: https://www.youtube.com/watch?v=FXSAG3bWKVcLearn more about AHLA's 2026 Health Care Transactions conference: https://www.americanhealthlaw.org/healthcaretransactionsLearn more about AHLA's 2026 Health Care Transactions eProgram: https://educate.americanhealthlaw.org/local/catalog/view/product.php?productid=1779 Essential Legal Updates, Now in AudioAHLA's popular Health Law Daily email newsletter is now a daily podcast, exclusively for AHLA Comprehensive members. Get all your health law news from the major media outlets on this podcast! To subscribe and add this private podcast feed to your podcast app, go to americanhealthlaw.org/dailypodcast.Stay At the Forefront of Health Legal EducationLearn more about AHLA and the educational resources available to the health law community at https://www.americanhealthlaw.org/.
Auto - Rund ums Auto. Fahrberichte, Gespräche und Informationen
Heute sprechen wir über den Leapmotor B10, da wollte ich doch mal wissen, was der Name bedeutet. Also Leapmotor. Da konnte mir auch die KI nicht weiterhelfen, immerhin wusste sei, dass Leapmotor ein chinesischer Hersteller von Elektrofahrzeugen mit Sitz in Hangzhou ist, der 2015 gegründet wurde und ein Joint Venture mit dem Autokonzern Stellantis hat. Ein Englisch – Deutsch Übersetzungstool sagt, es hieße übersetzt „Sprungmotor“. Angesichts der Beschleunigung könnte das sogar stimmen. Wieso der Begriff aus dem Westfriesischen kommen soll, ist mir aber ein Rätsel! Darum geht es diesmal!Ab und zu sticht mich bei der Erstellung meiner Fahrberichte der Hafer, dann kann ich mir einen Gag nicht verkneifen. Also: Stellen Sie sich mal vor, Ihnen kommt auf der B10 ein B10 entgegen. Das erste B10 steht für eine ca. 240 Kilometer lange Bundesstraße im Südwesten Deutschlands. Das zweite für ein Elektrofahrzeug aus dem Hause Leapmotor. Und da man bei Elektroautos immer über die Reichweite spricht, folgt später noch eine amüsante Rechnung. Das Outfit!Das elektrische C-SUV wurde von Leapmotor für Europa konzipiert, sein Exterieur ist ausdrucksstark. Es vereint elegante Kurven und klare, dynamische Linien zu einem markanten, modernen und jungen Look. Mit einer Länge von 4,51 Meter, einer Breite von 1,88 Meter und einer Höhe von 1,65 Meter ist der B10 perfekt für europäische Straßen geeignet. Testfahrten auf dem renommierten italienischen Testgelände Balocco haben das untermauert. Power und Drive! Kommen wir zum B10 auf der B10 und zu der besagten Rechnung zurück. Wenn besagter Leapmotor B10 mit einer kleinen Batterie ausgestattet ist, schaffen Sie die B10 einmal hin und ein ganzes Stück zurück mit einer Ladung. Mit der großen Batterie fehlt nur ein kleines Stück beim Rückweg. In Zahlen ausgedrückt sprechen wir von Reichweiten von 361 bzw. 434 Kilometern WLTP-Reichweite. Der B10 wird immer von einem hocheffizienten Elektromotor mit 160 kW (218 PS) angetrieben, der den Wagen aus dem Reich der Mitte in nur 8 Sekunden von 0 auf 100 km/h und auf eine Höchstgeschwindigkeit von 170 km/h beschleunigt. Leapmotor hat ihn unter anderem mit 17 ADAS-Funktionen und einem 360°-Kamerasystem ausgestattet. ADAS steht übrigens für Advanced Driver Assistance Systems, zu gut Deutsch: fortschrittliche Fahrerassistenzsysteme.Die Kosten!Der Leapmotor B10 steht ab 29.900, -- Euro mit der 56,2 kWh Batterie und 361 km Reichweite (WLTP) beim Händler. Mit einer Batteriekapazität von 67,1 kWh steigt die Reichweite auf bis zu 434 km (WLTP), der Preis auf 32.400 – Euro. Das ist ein gutes Angebot! Alle Fotos: © Leapmotor/Stellantis Diesen Beitrag können Sie nachhören oder downloaden unter:
Has Wall Street been looking at hyperscaler debt all wrong? Lance Roberts & Michael Lebowitz examine claims that the "hidden debt" of AI hyperscalers has surged to $1.65 trillion through off-balance-sheet obligations, including long-term leases and infrastructure commitments. But does that mean the AI investment thesis is breaking down? We'll separate the headlines from the fundamentals by comparing the financial strength of Microsoft, Amazon, Alphabet, Meta, and Oracle. While hidden obligations deserve attention, not all debt carries the same risk, and not every hyperscaler should be viewed through the same lens. 0:00 INTRO 1:02 - ISM Looking Good, MFG at 4-year High 4:13 - Markets Take a Rest - time to rebalance? 9:27 - Forward Returns After Breakout to New Highs 14:04 - Open Source AI vs Closed Source AI 17:18 - Who Benefits, Regardless of Source? (Who is the common denominator?) 22:31 - Hyperscaler Bear Porn - Look at the debt 24:53 - A Basket of Hyperscalers Does Not an Index Make 27:35 - What Does "Off Balance Sheet" Mean? (There Are Three Types) 28:27 - Data Center Leasing 30:32 - Joint Ventures 30:55 - Chip Leasing 35:20 - Listen to the Markets 38:34 - Busting Narratives; don't believe the hype Chief Investment Strategist, Lance Roberts, CIO, w Portfolio Manager, Michael Lebowitz, CFA Produced by Brent Clanton, Executive Producer ------- Do you enjoy our content? Rate us on Google: https://bit.ly/4b9JtEo ------- Watch Today's Full Video on our YouTube Channel: https://youtube.com/live/HeU8LWC2rfo?feature=share ------- Articles mentioned in this report: "Palantir Earnings Provide Hope For The Software Sector" https://realinvestmentadvice.com/resources/blog/palantir-earnings-provide-hope-for-the-software-sector/ "Hidden Debt: Is Our Hyperscaler Thesis Wrong – Part 2" https://realinvestmentadvice.com/resources/blog/hidden-debt-is-our-hyperscaler-thesis-wrong-part-2/ "Carnage In Hyperscaler Credit: Really?" https://realinvestmentadvice.com/resources/blog/carnage-in-hyperscaler-credit-really/ -------- Watch today's "Before the Bell" premarket commentary, "Time to Rebalance?" https://youtu.be/y7Er-AsOkFc ------- Watch our previous show, "Q&A Wednesday: Market Questions Answered" https://youtube.com/live/9KGokK9tGuA ------- Get more info & commentary: https://realinvestmentadvice.com/insights/real-investment-daily/ ------- * REGISTER for our next Dynamic Learning Series, "Savvy Medicare Planning: Everything You Need to Know Before You Enroll," Thursday, August 20, 2026: https://streamyard.com/watch/Qjx33M2tS4i4 --- Visit our Site: https://www.realinvestmentadvice.com Contact Us: 1-855-RIA-PLAN --- Subscribe to SimpleVisor : https://www.simplevisor.com/register-new --- Connect with us on social: https://twitter.com/RealInvAdvice https://twitter.com/LanceRoberts https://www.facebook.com/RealInvestmentAdvice/ https://www.linkedin.com/in/realinvestmentadvice/ #StockMarket #Investing #PortfolioManagement #RiskManagement #MarketOutlook #ArtificialIntelligence #Technology #FinancialPlanning
From Invisible to Irresistible: Webinar Success & Strategic Growth with Nyrie RoosIn this episode, we explore how women in business can scale sustainably, avoid burnout, build strong marketing foundation. How to leverage webinars and partnerships strategically with Nyrie Roos from Explosion Marketing.Marketing strategist and webinar conversion specialist Nyrie Roos joins me for my 200th podcast interview.She delivers a masterclass on building a business that is both profitable and sustainable.With over $47 million in webinar sales generated and decades of experience in lead generation, conversion optimisation, and automated funnels, Nyrie brings a grounded, practical approach to online marketing. In this conversation, she shares how collaboration, focus, and strong foundations can dramatically improve business outcomes—especially for women who often feel stretched thin trying to “do it all.”Nyrie explains the difference between Joint Ventures and Affiliate Partnerships, how to test your offers before scaling, and why strategy—not tactics—is what prevents burnout and creates predictable growth.She also emphasises the power of good communication with your database and why staying true to your mission is vital when distractions are everywhere.Women in business face challenges such as inconsistent client acquisition, wearing too many hats, and uncertainty around how and when to use AI. Nyrie unpacks each challenge and offers clear steps to overcome them so your time and energy can stay focused on your zone of genius.Whether you're launching webinars, strengthening your marketing systems, or planning for a more aligned business year ahead, this episode offers powerful insights you can apply immediately.Key Takeaways for Webinar and Business Success Have a clear plan and follow it consistently Review your plan regularly to stay aligned Don't deviate from your mission — stay focused on what you truly want Build strong foundations before scaling Collaboration and expert support can fast-track growth Guest Contact DetailsEmail: nyrie@explosionmarketing.com.auPhone: 0439 558 606Business: Explosion MarketingSocial Links:LinkedIn: https://www.linkedin.com/in/nyrieroosleads/YouTube: https://www.youtube.com/@ExplosionMarketingWe Are Women Podcast Host — Janeen VosperJaneen Vosper is a Brand Authority Specialist, international speaker, and host of the We Are Women Podcast. With decades of experience in sales, communication, and storytelling, she helps professionals develop a confident voice, craft powerful brand stories, and build authentic connections that convert.Website: www.janeenvosper.comLinkedIn: https://www.linkedin.com/in/janeenvosperbrandauthorityspecialist/ If you enjoyed this episode, subscribe to the We Are Women Podcast on your favourite listening platform or on YouTube — and share it with women who are ready to build a more focused, strategic, and sustainable business.
- Three Chinese Automakers Crack Global Top Ten - General Motors Extends SAIC Joint-Venture - U.S. Car Sales Dip 1.4% In July - BYD PHEV Can Run on Ethanol - Honda Revenue Soars Despite Plummeting Asian Sales - Lucid Cuts Shifts and Delays New SUV Launch - Uber Profit Surges but Misses Market Expectations - Geely Wins Top Honors for Chassis Innovation - Koenigsegg Debuts 800-HP Raxial Flux Motor
- Three Chinese Automakers Crack Global Top Ten - General Motors Extends SAIC Joint-Venture - U.S. Car Sales Dip 1.4% In July - BYD PHEV Can Run on Ethanol - Honda Revenue Soars Despite Plummeting Asian Sales - Lucid Cuts Shifts and Delays New SUV Launch - Uber Profit Surges but Misses Market Expectations - Geely Wins Top Honors for Chassis Innovation - Koenigsegg Debuts 800-HP Raxial Flux Motor
Commercial Property Finance - Products, Structure and Strategy
A little throwback again, as this has come up so much this past few weeks...It's how to pitch a JV successfully! ▶︎ Website - www.thepropertyfinancecollective.co.uk▶︎ The Host - With a passion for creative finance and the ability to structure deals for Finance, I love helping first time Developers and Investors to get deals packaged for the finance needed to push Property Careers forward, and to date I have raised over £500 million for Developers and Investors. I first got into property at the age of 18 when I got into Conveyancing straight out of school. I then went into Estate Agency, back into Conveyancing and I then got into brokering at the age of 22. I decided a year and a half later that I wanted to work for myself and try and shake up the market place! At the age of 24 I set up The Property Finance Guy and became the youngest owner of a Commercial Finance Brokerage in the Country, and alongside this I now also have a successful Training Company, educating Investor and Developers on how to raise finance, and a successful Podcast.I am a keen public speaker and have delivered training and speeches to over 1000 investors and developers over the past 2 years.Follow Michael:▶︎ Facebook - https://www.facebook.com/thepropfinguy/▶︎ Instagram - https://www.instagram.com/thepropertyfinanceguy/▶︎ LinkedIn - https://www.linkedin.com/in/michael-primrose-886a365b/?originalSubdomain=ukListen to the Podcast on:▶︎ Apple Podcasts - https://podcasts.apple.com/gb/podcast/the-property-finance-podcast/id1448207494▶︎ Spotify - https://open.spotify.com/show/7JiDtm7hc0EfSW9LjCXDaO▶︎ YouTube - https://youtube.com/@thepropertyfinanceguy▶︎ Disclaimer - With the market changing so quickly, the content could be out of date at the time of listening.This Content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice.
Cette semaine, nous recevons Jean-Philippe Décarie-Mathieu, du balado « Les Drôlistes ». Laurent revient sur l'annonce de « Marvel Studios » concernant l'ajout de Ryan Gosling à la distribution de « Ghost Rider », réalisé par Shawn Levy, la rencontre entre Ralph Macchio, vedette de « The Karate Kid », et son homologue de « Marvel Comics », ainsi que sur la nouvelle série « The Demon », écrite et illustrée par James Harren. Pour sa part, Benoit revient sur ses soirées passées aux galas de lutte de Sans Restriction Chrono et de Mystery Wrestling, ainsi que sur le Pay-per-view Redemption de la AEW. Il aborde également les annonces entourant l'arrivée des Muppets chez Marvel, la nouvelle minisérie Indiana Jones de Marvel Comics scénarisée par Jason Aaron, ainsi que le jeu vidéo « Jay and Silent Bob's Joint Venture ». En dernière partie d'émission, l'équipe discute « Blood Hunt » de Jed MacKay et Pepe Larraz. Consulter l'ensemble de nos archives: https://www.mysterieuxetonnants.com/category/podcasts/emission/ Laissez-nous un message vocal: https://www.speakpipe.com/mysterieuxe Devenez membre de la communauté Patreon: https://www.patreon.com/MysterieuxE Diffusion originale : 3 août 2026 Site web : MysterieuxEtonnants.com © Les Mystérieux Étonnants. Tous droits réservés
Disputes arising out of construction and infrastructure joint-venture projects This podcast explores the rising complexity of disputes in infrastructure joint ventures and the key issues that drive them. With large-scale, long-term projects bringing together multiple parties, the potential for disagreement is inherent. In this episode, we discuss: 1) why infrastructure joint ventures are particularly prone to complex disputes, given their scale, duration, capital intensity and the interdependence of responsibilities; 2) the most common areas of contention, including funding and capital calls, governance and deadlock, exit and valuation, as well as downstream construction disputes involving scope changes, cost overruns and the relationship between JV entities and their participants; and 3) key takeaways for C-suite executives and lawyers. 本期我们专注基础设施合资企业中日益复杂的争议问题及其主要成因。大型、长期的基础设施项目汇集了多方参与者,分歧的产生在所难免。在本期节目中,我们将围绕以下三个方面展开讨论:1)首先,我们将分析为何基础设施合资企业特别容易引发复杂争议,包括项目规模大、周期长、资本密集以及各方责任高度交织等因素 ;2)其次,我们将探讨最常见的争议领域,涵盖出资与增资催缴、治理与僵局、退出与估值,以及涉及范围变更、成本超支和合资实体与参与方之间关系的下游施工争议 ;3)最后,我们将为企业高管和法律从业者提供关键建议。
Send us Fan Mail
Send us Fan Mail
In this episode, Molly Gamble, Vice President of Editorial at Becker's Healthcare, discusses the growing trend of health system joint ventures, including the AdventHealth and Intermountain partnership, and how organizations are pursuing scale, flexibility, and strategic growth through new deal models.
China's growing use of economic power for strategic and political purposes has become one of the defining features of international competition. Beijing is no longer simply using trade and investment to promote economic growth—it is increasingly deploying a sophisticated toolkit of laws, regulations, export controls, market access, infrastructure investment, and technological standards to advance its broader geopolitical objectives. In today's episode, we'll explore how China's approach to economic statecraft has evolved, how effective it has been, its impact on Chinese foreign policy – especially relations with the United States -- and what governments around the world can do in response. I'm delighted to be joined by Dr. Evan Medeiros, one of the leading experts on Chinese foreign policy, including its use of economic statecraft, to help us unpack these important issues. Dr. Medeiros is the Penner Family Chair in Asia Studies in the School of Foreign Service and the Cling Family Distinguished Fellow in US-China Studies at Georgetown University. He served seven years in President Obama's NSC first as director for China, Taiwan and Mongolia, and then as Special Assistant to the President and Senior Director for Asia. Timestamps: [00:00] Introduction [01:49] What is Chinese Economic Statecraft? [04:52] How Chinese Leaders Think About Economic Power and Political Influence [06:43] The Evolution of China's Economic Statecraft Toolkit [09:49] Chinese Market Accessibility as Statecraft [14:07] Institutionalizing Economic Statecraft [17:37] How Legal Bodies are Implemented [23:32] Implications for the US-China Relationship [25:36] Strengthening US Economic Statecraft
- DOJ Fain Probe May Extend UAW Federal Oversight - Honda Shrinks in China but Extends GAC Partnership - Honda Considers Building New North American Plant - China Auto Suppliers Pivot to Booming Motorcycle Sector - U.S. EV Sales Stabilize in May - Electric Cars Outsell All Other Powertrains in Germany - China Quietly Restricts Rare Earth Exports to U.S. - Struggling Aston Martin in Talks for New Liquidity
- DOJ Fain Probe May Extend UAW Federal Oversight - Honda Shrinks in China but Extends GAC Partnership - Honda Considers Building New North American Plant - China Auto Suppliers Pivot to Booming Motorcycle Sector - U.S. EV Sales Stabilize in May - Electric Cars Outsell All Other Powertrains in Germany - China Quietly Restricts Rare Earth Exports to U.S. - Struggling Aston Martin in Talks for New Liquidity
In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD (academic clinical lecturer in rheumatology, University of Leeds), and Rihards Buss, MD (consultant rheumatologist, Freeman Hospital, Newcastle), record a post-EULAR 2026 debrief, working through the abstracts each identified as the meeting's most consequential. The conversation spans cellular therapies in autoimmune disease, proteomic biomarkers for treatment selection in RA, a landmark head-to-head trial in psoriatic arthritis, evolving classification criteria for axial spondyloarthritis, and the first phase III randomized controlled trial of a JAK inhibitor in polymyalgia rheumatica.Studies featured in this episode include: AB-101 Allogeneic NK Cell Therapy in Rheumatologic Diseases (LB0003) CARLYSLE: Obe-Cel CAR T in Severe Refractory SLE (OP0341) Ex Vivo Proteomic Signatures of JAK and TNF Inhibitors Predict Treatment Response in RA (OP048) BE BOLD: Bimekizumab vs Risankizumab in PsA (LB0001) 2025 ASAS-SPARTAN Revised AxSpA Classification Criteria (OP0236, OP0239, POS0190, POS1341) JAK-SPARE: Baricitinib in Early Polymyalgia Rheumatica (LB0005) Click here to read more and watch the full video at RheumatologyLive.
Ross has been taking notes and wants a follow up conversation on the ways that physical play creates an entry point for social relationships. Tom points out how joint ventures in the physical world create openings for friendship—bumping cars, filling big buckets with sand. Joey is reminded of recent statue game where physical play was a path to quickly forming relationships. Mike wonders if physical games are more like choreography than a written script. In the end, do we just need more time for play?
**Think passive real estate investing only means buying rental properties? Think again.** In this episode, G. Brian Davis and Denise break down **8 high-yield passive investment opportunities** that can help you build wealth, diversify your portfolio, and generate income—without becoming a full-time landlord. Whether you're an experienced investor or just getting started, you'll learn how to evaluate different passive strategies, understand their risks, and decide which investments may fit your financial goals. ### **
Paul Moore is the principal at Wellings Capital, based in Lynchburg Virginia. On today's show we're talking about how the investment thesis has changed in response to market conditions. To connect with Paul visit https://www.wellingscapital.com/They also have a number of resourcesincluding their due diligence checklist available on their resources page at https://www.wellingscapital.com/resources-----------------**Real Estate Espresso Podcast:** Spotify: [The Real Estate Espresso Podcast](https://open.spotify.com/show/3GvtwRmTq4r3es8cbw8jW0?si=c75ea506a6694ef1) iTunes: [The Real Estate Espresso Podcast](https://podcasts.apple.com/ca/podcast/the-real-estate-espresso-podcast/id1340482613) Website: [www.victorjm.com](http://www.victorjm.com) LinkedIn: [Victor Menasce](http://www.linkedin.com/in/vmenasce) YouTube: [The Real Estate Espresso Podcast](http://www.youtube.com/@victorjmenasce6734) Facebook: [www.facebook.com/realestateespresso](http://www.facebook.com/realestateespresso) Email: [podcast@victorjm.com](mailto:podcast@victorjm.com) **Y Street Capital:** Website: [www.ystreetcapital.com](http://www.ystreetcapital.com) Facebook: [www.facebook.com/YStreetCapital](https://www.facebook.com/YStreetCapital) Instagram: [@ystreetcapital](http://www.instagram.com/ystreetcapital)
Last Monday, Verizon and BT unexpectedly announced a joint venture that would combine their international enterprise operations. The new business is expected to serve more than 3,000 customers across more than 180 countries, representing roughly $4 billion in combined annual revenue. Their enterprise customers were the last to know. The proposed Verizon/BT joint venture raises an important question for enterprise customers with multinational operations: is this proposed JV simply a new international platform, or is it a signal that Verizon is effectively exiting parts of the enterprise network market? The Verizon/BT JV will undoubtedly create real confusion around supplier competition, account ownership, contracting entities, pricing leverage, service accountability, and long-term network strategy. And of course, tie-ups between two competing network providers have a notable history of failure. In this 14-minute episode of Staying Connected, Tony Mangino is joined by TC2's Brent Knight and Ben Fox to discuss what the Verizon/BT joint venture means for multinational enterprise customers, why Verizon's commitment to the enterprise-market is a question worth asking and how enterprise customers can protect their sourcing strategy, contract posture, pricing position and operational control during the transition window. If you would like to learn more about our experience in this space, please visit our Strategic Sourcing webpage.
If you're trying to win federal contracts with no past performance, this episode breaks down exactly how 8(a) joint ventures solve that problem. A govcon consultant walks through how he used JV partnerships and tribal 8(a) entities to win sole source work before his own company had a track record, and why relationships built over decades still beat any cold outreach strategy. Whether you're new to federal contracting or scaling an 8(a) firm, this is a real-world playbook for bridging the past performance gap. How to use JV partnerships to win sole source contracts before you have your own past performance Why tribal 8(a) entities like Spokane offer unique advantages for forming joint ventures How SBA's three-project rule determines how long an 8(a) JV can last What contracting officers and capability statements look for from a new 8(a) company Why decades-long relationships outperform cold pitches when finding JV partners EPISODE CHAPTERS: 0:00 - Mindy AI introduction and federal opportunity research 0:30 - Starting a new tribal 8a company from scratch 1:36 - Building capability statements and attending industry conferences 2:48 - Using JV and teaming partners before getting your own 8a 3:52 - Building past performance through JV projects over time 4:42 - How relationships lead to forming joint venture partnerships 6:03 - Negotiating pay and structuring the tribal 8a business plan 7:03 - Using JV past performance versus your own capability statement 8:18 - SBA three project rule and how long a JV lasts 9:21 - Keeping JV partners busy with self-performed work Mindy gives you the federal opportunities, agency signals, recompete intel, and pursuit briefs that tell you not just what contracts exist, but which ones to chase and how to win them. Sign up for free Daily Alerts and get opportunities delivered to your inbox before the day starts.
Bloomberg reported that Verizon and BT plan a joint venture combining their international enterprise units. The move would consolidate managed network services across multiple regions and could offer single-contract models for multinational customers. Regulatory approvals will likely be required in the United Kingdom, the United States, and other jurisdictions, with reviews focused on competition, security, and data residency. Integration will involve aligning OSS and BSS systems, product catalogs, and support workflows, creating potential migration risk. Customers should audit contracts, confirm assignment and SLA terms, and evaluate secondary providers for critical routes. Partners and vendors should prepare for centralized procurement and larger, consolidated bids for networking and cloud connectivity solutions.Learn more on this news by visiting us at: https://greyjournal.net/news/ Hosted on Acast. See acast.com/privacy for more information.
Shaping a government solicitation before the RFP drops is one of the most powerful competitive moves a small business can make and in this episode, Ryan Atencio walks through a live sources sought response strategy designed to nudge an active DoD training requirement toward a small business set-aside on Seaport Next Generation. This is real BD strategy in action, not theory. How to structure a sources sought response that recommends minimum requirements, acquisition strategy, and contract type all designed to eliminate low-price technically acceptable (LPTA) races to the bottom and filter out unqualified competitors Why joint venturing with the large business incumbent before the solicitation drops is the smartest teaming play a small business can make, and how to position that JV as a zero-risk transition solution for the contracting officer The staffing and recruiting mindset that drives wins in professional services contracting why putting the right people in seats is the only skill that truly matters for service contract capture How to use past performance from elite DoD customers like Naval Special Warfare (SEAL Teams) to build confidence with risk-averse contracting officers who hate change Why Eric prices every bid as if it is LPTA regardless of contract type and how that discipline keeps him competitive even when best-value trade-off evaluations are in play EPISODE CHAPTERS: 0:00 - Introducing Mindy AI and the federal research gap 0:30 - Welcome to the Federal Help Center podcast 0:52 - Seaport NxG strategy to cut out LPTA competition 1:20 - Why staffing and recruiting wins all service contracts 1:50 - Using elite past performance to build contracting officer confidence 2:48 - Why customers want the incumbent and how to neutralize that 3:17 - Joint venturing with T3i as a zero-risk transition play 4:17 - Writing industry recommendations that shape the requirement 5:14 - Pushing the set-aside, contract type, and NAICS strategy 5:39 - Pricing everything like LPTA even on best-value awards 6:36 - Adding specialized capabilities like UAS and pyro to the requirement 8:03 - Firm fixed price versus time and materials risk explained 9:55 - Final thoughts on small business set-aside advantages Mindy gives you the federal opportunities, agency signals, recompete intel, and pursuit briefs that tell you not just what contracts exist, but which ones to chase and how to win them. Sign up for free Daily Alerts and get opportunities delivered to your inbox before the day starts.
In this episode of Joint Ventures, host Rihards Buss, MD, consultant rheumatologist, Freeman Hospital, Newcastle, sits down with Sarah Dyball, MBBS, PhD, academic clinical lecturer, Centre for Musculoskeletal Research, University of Manchester, and Kate Harnden, MBChB, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, at the European Alliance of Associations for Rheumatology (EULAR) 2026 annual congress in London.Click here to watch the episode.
The therapeutic framework for systemic sclerosis is undergoing a fundamental reorientation, moving away from managing visible fibrotic sequelae toward targeting the autoantibody-driven mechanisms believed to initiate and propagate disease.On a recent episode of Joint Ventures recorded live at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress in London, host Jack Arnold, MBBS, PhD, of the University of Leeds, spoke with Vishal Kakkar, MD, also of the University of Leeds and a specialist in scleroderma, about the most consequential data emerging from the congress.Click here to watch the episode.
In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, academic clinical lecturer in rheumatology, University of Leeds, was joined at the European Alliance of Associations for Rheumatology (EULAR) 2026 annual congress in London by Laurence Duquenne, MD, a rheumatology researcher, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, an investigator on one of the meeting's standout studies to examine whether baseline naïve CD4+ T cell frequency can identify which newly diagnosed patients with rheumatoid arthritis (RA) are unlikely to respond to methotrexate monotherapy, and whether adding a biologic at the outset can close that gap.Click here to watch the episode.
This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Gary Herschman, Healthcare Transactions Shareholder, Baker Donelson, and Dana Jacoby, President & CEO, Vector Medical Group. Here, they discuss how joint ventures and strategic partnerships are evolving across musculoskeletal care and explore the growing role of physicians, hospitals, private equity, payers, and ASC operators in shaping future care models, governance structures, and value creation strategies.This episode is sponsored by Baker Donelson.
This episode recorded live at the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference features Gary Herschman, Healthcare Transactions Shareholder, Baker Donelson, and Dana Jacoby, President & CEO, Vector Medical Group. Here, they discuss how joint ventures and strategic partnerships are evolving across musculoskeletal care and explore the growing role of physicians, hospitals, private equity, payers, and ASC operators in shaping future care models, governance structures, and value creation strategies.This episode is sponsored by Baker Donelson.
Blue Alpine Cast - Kryptowährung, News und Analysen (Bitcoin, Ethereum und co)
Jetzt bei Kraken anmelden und 30 EUR Bonus erhalten: https://bit.ly/kraken-bonusThemen & Timestamps:00:00 Begrüssung und Themenüberblick00:38 Bitcoin-Funding-Rate und der Weg zu 70'000 Dollar03:08 KI-Agenten als Treiber des nächsten Bullruns04:53 Trump unterzeichnet Executive Order zu Quantencomputern06:29 Neues Staking- und Mining-Steuergesetz in den USA08:32 Partnerschaft zwischen ICE und OKEx10:32 Binance, die MiCA-Lizenz und das Eurotrading in Europa
We hebben het over Kevin Warsh, kersverse baas van de Fed. Op zijn eerste persconferentie maakte hij duidelijk dat het anders moet. De afgelopen vijf jaar heeft de Amerikaanse centrale bank de doelstelling niet gehaald en dat gaat hij nu anders doen. De Fed gaat op de schop. Er komen vijf werkgroepen die onderzoek wat er moet veranderen. Eén ding is al gelijk aangepast: de schriftelijk verklaring. Die is drastisch ingekort. Alleen doet hij niet wat hij (van president Trump) moet doen en dat is de rente verlagen. Sterker nog, die gaat dit jaar zo goed als zeker omhoog. Deze aflevering kijken we wat dit alles betekent voor jou en of hij jou óók teleurstelt. Tim Cook komt ook voorbij. De vertrekkend ceo van Apple kwam met slecht nieuws voor klanten. De prijzen moeten omhoog, want de inkoop van chips is veel te duur geworden. Opvallend, want Apple was een van de laatste technologiebedrijven die het tekort aan geheugenchips juist de baas bleef. We hebben het ook over de beleggersdag van Besi. Daar is voor ons Jordy Beuving van De Aandeelhouder. Hij vertelt waarom Besi zijn omzet- en winstdoel flink verhoogt en vertelt meer over de orders voor hun paradepaardje. Verder ook aandacht voor Box 3, de Iran-deal en Maserati. Te gast: Hans Oudshoorn van Saxo (die ook meer vertelt over investeren in netcongestie) BNR Beurs is een journalistiek onafhankelijke productie, mede mogelijk gemaakt door Saxo. Over de makers: Jelle Maasbach is presentator van BNR Beurs en freelance financieel journalist. Zijn favoriete aandeel om over te praten is Disney, maar daar lijkt hij de enige in te zijn. Sinds de eerste uitzending van BNR Beurs is 'ie er bij. Maxim van Mil is presentator van BNR Beurs en journalist bij BNR, waar hij zich focust op de financiële markten en ontwikkelingen in de tech-wereld. Je krijgt hem het meest enthousiast als hij kan praten over ASML, of oer-Hollandse bedrijven zoals Ahold of ABN Amro. Jorik Simonides is presentator van BNR Beurs, economieredacteur en verslaggever bij BNR. Hij wordt er vooral blij van als het een keer níet over AI gaat. Je hoort hem ook in de BNR-podcast Moerdijk: dorp van de rekening. Milou Brand is presentator van BNR Beurs, freelance podcastmaker en columnist bij het Financieele Dagblad. Jochem Visser is presentator van BNR Beurs, maakt Beursnerd XL en is redacteur bij de podcast Onder Curatoren. Vraag hem naar obscure zaken op financiële markten en hij vertelt je waarom het eigenlijk nóg leuker is dan je al dacht. Over de podcast: Met BNR Beurs ga je altijd voorbereid de nieuwe beursdag in. We praten je in een kleine 25 minuten bij over alle laatste ontwikkelingen op de handelsvloer. We blijven niet alleen bij de AEX of Wall Street, maar vertellen je ook waar nog meer kansen liggen. En we houden het niet bij de cijfers, maar zoeken ook iedere dag voor je naar duiding van scherpe gasten en experts. Of je nu een ervaren belegger bent of net begint met je eerste stappen op de beurs, de podcast biedt waardevolle inzichten voor je beleggingsstrategie. Door de focus op zowel de korte termijn als de lange termijn, helpt BNR Beurs luisteraars om de ruis van de markt te scheiden van de essentie. Van Musk tot Microsoft en van Ahold tot ASML. Wij vertellen je wat beleggers bezighoudt, wie de markten in beweging zet en wat dat betekent voor jouw beleggingsportefeuille.See omnystudio.com/listener for privacy information.
Government contract joint ventures and teaming agreements can unlock multi-million dollar opportunities — but one compliance mistake can cost you your small business status before you ever perform a day of work. In this episode, govcon veteran David Rambhajan breaks down exactly how to structure partnerships the right way so you win bids, stay compliant, and never get blindsided by an affiliation ruling. Affiliation risk in prime-sub relationships — Learn why subcontracting too much work to a large business can trigger an SBA affiliation finding that strips your small business designation on a live solicitation. Teaming agreements vs. prime-sub contracts — Understand the critical difference between an informal subcontract and a formal teaming agreement, and when a teaming agreement actually reduces your affiliation exposure with the government. Using teaming agreements to unlock bonding capacity — David reveals how a six-month-old small business used a teaming partner's indemnification to secure a multi-million dollar bond — and what the compliance letter requirement means for your bid protest strategy. Joint venture structure and the 51% ownership rule — Discover why a large business holding even 49% of your JV can disqualify it as a small business — and the one exception under the SBA Mentor-Protégé Program that changes everything. SDVOSB set-asides vs. veteran-owned set-asides — David clarifies a common misconception: current set-asides target service-disabled veteran-owned businesses, not all veteran-owned businesses, and what a pending legislative change could mean for your competition pool. EPISODE CHAPTERS: 0:00 - Introduction to govcon partnership rules and risks 0:30 - Welcome to the Federal Help Center podcast with Eric Coffie 1:00 - Affiliation risk when subcontracting to large businesses 2:05 - Self-performance requirements in construction vs services 2:45 - Why clear expectations prevent teaming relationship failures 3:14 - How teaming agreements differ from prime-sub contracts 4:05 - Real story of a six-month-old business winning a bonded contract 5:09 - Teaming agreements and bond indemnification compliance letters 7:35 - When teaming with large businesses reduces affiliation exposure 9:02 - Joint ventures as separate legal entities with tax IDs 9:44 - The 51% ownership rule and large business JV disqualification 10:16 - Mentor-protégé program and the billion dollar JV bid story 12:09 - SDVOSB set-aside rules and the veteran-owned business distinction 13:07 - Final compliance takeaway and community call to action Mindy gives you the federal opportunities, agency signals, recompete intel, and pursuit briefs that tell you not just what contracts exist, but which ones to chase and how to win them. Sign up for free Daily Alerts and get opportunities delivered to your inbox before the day starts.
In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle, preview their unofficial countdown of the sessions, themes, and abstracts they are most excited about heading into the 2026 European Alliance of Associations for Rheumatology (EULAR) Annual Meeting in London, June 3–6, including: Obesity, Weight Management, and Psoriatic Arthritis Sessions Personalized Medicine and Biomarkers in RMDs Sessions Fatigue and Quality of Life in Connective Tissue Disease Session Mitochondrial DNA and Interferon: Upstream Drivers of Autoimmunity Session Artificial Intelligence and Pattern Recognition in Rheumatology Sessions Axial Imaging in Axial Spondyloarthritis Session Head-to-Head Superiority Trials in RA and PsA Sessions CAR-T and CAR-NK Therapies: Efficacy, Limits, and What Comes Next Sessions
In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle, are joined by guest Lucy Carter, MBBS, PhD, a consultant rheumatologist at Newcastle upon Tyne NHS Foundation Trust and honorary clinical senior lecturer at Newcastle University, to examine nearly 2 decades of B cell–targeted therapy in rheumatic disease — a story that has proven considerably more complicated than its early promise suggested.Carter, Arnold, and Buss trace the mixed legacy of rituximab in lupus and Sjögren disease and examining how incomplete B cell depletion, BAFF-driven rebound, and trial design limitations may have contributed to disappointing early results. The discussion then turns to newer approaches such as obinutuzumab, whose positive REGENCY and ALLEGORY trial data in lupus nephritis and systemic lupus erythematosus suggest that deeper, more durable B cell depletion may improve outcomes, while emerging CAR-T data raise broader questions about the future role of intensive immune reprogramming in autoimmune disease.
In the second part of this Joint Ventures episode on B cell therapies in rheumatic disease, hosts Jack Arnold, MBBS, PhD, and Rihards Buss, MD, return with guest Lucy Carter, MBBS, PhD, to move beyond the question of how to deplete B cells and toward the more conceptually challenging problem of what happens after depletion — and whether ianalumab's dual mechanism of action represents the most rational answer yet developed.The episode examines the biologic rationale behind combining rituximab with belimumab, reviews the landmark NEPTUNUS Sjögren disease trials in which ianalumab became the first targeted therapy to meet a phase 3 primary endpoint in the disease, and discusses how emerging therapies may ultimately reshape treatment selection, steroid reduction strategies, and long-term management of autoimmune conditions including Sjögren disease and systemic lupus erythematosus.
In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle, turn from osteoarthritis to the inflammatory arthritides — examining what early data in rheumatoid arthritis (RA), psoriatic arthritis (PsA), and lupus can and cannot yet tell us about the role of GLP-1 receptor agonists in disease modification.“Everyone is talking about [GLP-1 RAs] and what it can do for our patients. Much more evidence is needed to be much more better understanding about increasing effects beyond weight loss is needed. And I think that evidence will be just coming out very rapidly, year by year… but I think this is not the case where we're going to wait for strong evidence, good quality RCT data before we start to start to use them,” Buss said.
In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MD, a consultant rheumatologist at Freeman Hospital, Newcastle, examine the growing evidence for GLP-1 receptor agonists in rheumatological disease — drugs originally developed for glycemic control that are now drawing serious attention as potential immunomodulators with implications across the specialty.The conversation opens by tracing the arc of GLP-1 agonist development, from exenatide's approval in 2005 through to semaglutide's landmark cardiovascular and renal data in the SELECT1 and FLOW2 trials, before turning to the question now quietly circulating in rheumatology clinics: are these drugs doing something beyond shifting weight?
In this episode of Joint Ventures, hosts Jack Arnold, MBBS, PhD, an academic clinical lecturer in rheumatology at the University of Leeds, and Rihards Buss, MBBS, a consultant rheumatologist at Freeman Hospital, dive into 2 emerging therapeutic strategies with the potential to reshape care for systemic lupus erythematosus (SLE) and psoriatic arthritis (PsA): Fc receptor blockade with nipocalimab and tyrosine kinase 2 (TYK2) inhibition with deucravacitinib, distinct pathways united by a shared goal of greater precision in immune modulation.
Introducing Joint Ventures — a new podcast exploring advances in rheumatologic disease and what they mean for real-world practice. Hosted by RheumatologyLive, the series is led by Jack Arnold, MBBS, PhD, and Rihards Buss, MBBS, 2 United Kingdom-based rheumatologists united by a shared interest in translating rapidly evolving science into thoughtful, patient-centered care.Joint Ventures is designed for rheumatologists and clinicians managing immune-mediated disease who are navigating an increasingly complex therapeutic landscape. Each episode will examine emerging evidence, new mechanisms of action, and shifting paradigms in rheumatology, with a focus on how these developments intersect with clinical reasoning, uncertainty, and long-term patient management.Arnold is an academic clinical lecturer in rheumatology at the Leeds Institute of Rheumatic and Musculoskeletal Medicine in University of Leeds, with research interests spanning systemic lupus erythematosus, clinical trials, and the application of deep learning in medicine. Buss is a consultant rheumatologist specializing in psoriatic arthritis at Newcastle's Freeman Hospital, with a particular focus on integrating new data into day-to-day clinical decision-making.
French-Italian auto group Stellantis and China's Dongfeng have announced a plan to launch a joint venture based in Europe, with Stellantis having a 51 percent controlling stake. The deal would see Dongfeng's new electric models assembled at Stellantis's plant in western France to comply with the EU's new "Made in Europe" rule that requires 70 percent of EV content to be made locally. Also in the segment: one man in the US has turned a broken pink Barbie car into a solution to combat soaring fuel prices.
In this throwback episode from 2023 Alan revisits a long-standing "chip on his shoulder": the persistent and often unscientific demand for antibiotic premedication in joint replacement patients. Sparked by his own wife's hip surgery, Alan dives into the disconnect between evidence-based ADA/AAOS guidelines and the "premedicate for life" culture maintained by many orthopedic surgeons. With his signature wit and candid frustration, he explores the risks of antibiotic resistance, the myth of dental-induced bacteremia, and the awkward "middle man" position patients are forced into when dental and surgical philosophies collide. Some links from the show: "Meet the new guidelines. Same as the old guidelines" ADA joint premedication guidelines AAOS joint decision tree website AAOS premedication guidelines Join the Very Dental Facebook Group using one of these passwords: Timmerman, Paul, Bioclear, Hornbrook, Gary, McWethy, Papa Randy, Frank or Lipscomb! The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! We're proud to be supported by the folks at Net32! I'm a big fan of the Bioclear Method! I think you should give it a try and I've got a great offer to help you get on board! Use the exclusive Very Dental Podcast code VERYDENTAL8TON for 15% OFF your total Bioclear purchase, including Core Anterior and Posterior Four day courses, Black Triangle Certification, and all Bioclear products. Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code "VERYSHIP" you'll get free shipping on your order! Go save yourself some money and support the show all at the same time! The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!
Plus: Chip startup Cerebras Systems sets IPO price. And GameStop makes an unsolicited $56 billion offer to buy eBay. Imani Moise hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices
Dov returns to the podcast to talk about his new masterclass, the importance of partnerships, and much more!
The Hilarious and Sexy New Film Will Be Coming to Theaters April 24! Winner of the Special Jury Prize at Sundance, TWO WOMEN is an irrepressible comedy about two mothers who refuse to settle for stagnant lives and instead pursue the joy they need to feel alive and fulfilled. When neighbors Violette (Laurence Leboeuf) and Florence (Karine Gonthier-Hyndman) bond over the ennui of parenthood, they realize that the solution to reviving their joie de vivre may be in listening to their libidos. As the two start finding sex in unexpected places, they examine the larger unfulfilled needs that brought them to their current moment and choose to pursue a life of joy over compromise. Director Chloé Robichaud captures the Montreal winter in sumptuous 35mm film; Screenwriter Catherine Léger has adapted her own stage play, itself an update of the 1970 Quebecoise classic Two Women in Gold. Sophie Nélisse, Juliette Gariépy, Mani Soleymanlou, and Félix Moati complete a stellar ensemble cast. Wonderfully layered, empathetic, sexy, and fun, TWO WOMEN urges us to consider that life is not a straight line and to remember that there are infinite kinds of pleasure we can experience together if we simply allow ourselves to give in. Connect: The Film and Director The Film: @twowomenmovie Director (Chloé Robichaud): @chloerobish The Stars Laurence Leboeuf (Violette): @lorleb Karine Gonthier-Hyndman (Florence): @pennybobette The Distribution Team Joint Venture: @jointventurefilm About Joint Venture Joint Venture is an independent film studio that distributes each project by building coalitions with filmmakers, audiences, and partners across sectors. The company's release strategies are bespoke because an audience-centered, filmmaker-forward approach unlocks the greatest potential for each film. That's why it's a Joint Venture.
Trump declares victory after a last-minute ceasefire forces Iran to reopen the Strait of Hormuz, easing global oil disruptions and halting imminent U.S. strikes. With hundreds of ships still backed up, Trump proposes a controversial U.S.–Iran "joint venture" to secure the waterway and potentially manage transit operations together. As negotiations continue during the temporary truce, questions remain about whether this deal signals a true end to the conflict or just a pause before the next phase. Become A Member http://youtube.com/timcastnews/join The Green Room - https://rumble.com/playlists/aa56qw_g-j0 BUY CAST BREW COFFEE TO FIGHT BACK - https://castbrew.com/ Join The Discord Server - https://timcast.com/join-us/ Hang Out With Tim Pool & Crew LIVE At - http://Youtube.com/TimcastIRL